ArticlePloS one2025
Care cascade of hypertension across stages among older adults in India.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertension is now a common disease and the single largest risk factor for premature mortality in India. Hypertensive individuals are not homogenous and have varying risks to life. Although the number of studies on the care cascade of hypertension in India is increasing, no attempts have been made to estimate the prevalence and cascade of care across different stages of hypertension. This study estimates the prevalence, awareness, and treatment of hypertension by stages of hypertension among older adults in India. We analyzed data on 58,787 adults aged 45 years and above from the Longitudinal Ageing Study in India (LASI), Wave 1 (2017-18). Hypertension stages were categorized in accordance with the classification given by the Ministry of Health and Family Welfare, Government of India, and regrouped as per global classification. The age-sex adjusted prevalence, awareness, and treatment rates for different stages of hypertension were estimated. Multinomial logistic regression and the Erreygers' Concentration Index were used to assess socioeconomic inequalities in hypertension care. We estimated the prevalence of pre-hypertension at 39.9%, stage 1 hypertension at 22.1% and stage 2 hypertension at 9.9%. Increasing age and body mass index were associated with a higher chance of hypertension, whereas living with spouses and children meant having lower odds of hypertension across all stages. The economic condition of the household, educational attainment, and social groups were not significant predictors of hypertension across the stages. The awareness and treatment of hypertension were low across all the stages. The Erreygers' Concentration Index on awareness and treatment was pro-rich across all the stages of hypertension. A large proportion of hypertensive patients at the advanced stage remain undiagnosed and untreated and carry a higher risk of premature mortality. The awareness and treatment of hypertension are lower among the poorer and socially disadvantaged populations than their richer and more privileged counterparts across all stages.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.